bromo benzyl glutathione cyclopentyl diester BrBzGCp2 (S-p-Bromobenzylglutathione diester) | GLO1 Inhibitor Leveraging histone glycation for cancer
Leveraging histone glycation for cancer diagnostics and therapeutics: Trends in Cancer BENZOTHIAZOLE PROTEIN TYROSINE KINASE INHIBITORS Patent 1037632 Full article: GLUTATHIONE CONJUGATES AND THEIR SYNTHETIC DERIVATIVES AS INHIBITORS OF GLUTATHIONE DEPENDENT ENZYMES INVOLVED IN CANCER AND DRUG RESISTANCE S p bromobenzyl glutathione cyclopentyl diester (BBGC) as novel therapeutic strategy to enhance trabectedin anti tumor effect in soft tissue sarcoma preclinical models Oncogene
Pay in 4 interest-free payments of $5.17 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9


